Möhn, N.; Beutel, G.; Gutzmer, R.; Ivanyi, P.; Satzger, I.; Skripuletz, T.
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook. J. Clin. Med. 2019, 8, 1777.
https://doi.org/10.3390/jcm8111777
AMA Style
Möhn N, Beutel G, Gutzmer R, Ivanyi P, Satzger I, Skripuletz T.
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook. Journal of Clinical Medicine. 2019; 8(11):1777.
https://doi.org/10.3390/jcm8111777
Chicago/Turabian Style
Möhn, Nora, Gernot Beutel, Ralf Gutzmer, Philipp Ivanyi, Imke Satzger, and Thomas Skripuletz.
2019. "Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook" Journal of Clinical Medicine 8, no. 11: 1777.
https://doi.org/10.3390/jcm8111777
APA Style
Möhn, N., Beutel, G., Gutzmer, R., Ivanyi, P., Satzger, I., & Skripuletz, T.
(2019). Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook. Journal of Clinical Medicine, 8(11), 1777.
https://doi.org/10.3390/jcm8111777